Introduction
Primary familial brain calcification (PFBC), otherwise known as Fahr's disease, is an autosomal dominant condition that leads to bilateral brain calcifications. Four causative genes have been identified, including SLC20A2 which encodes a cellular phosphate transporter [1] . Associated clinical symptoms have variable penetrance and include cognitive impairment, psychiatric disorders, and movement disorders; five to ten percent of patients also have epilepsy [2] . Detailed characterization of epilepsy in PFBC including ictal EEG has not been reported. We describe a paediatric patient with PFBC presenting with refractory focal epilepsy based on history and ictal EEG.
Case summary
A 5-year-old Caucasian boy presented with tonic clonic seizures that were generalized in semiology but which had a left frontal onset on electroencephalogram (EEG). Magnetic resonance imaging (MRI) of the brain was initially unrevealing. Seizures were controlled with oxcarbazepine until age 11 years when the patient developed several new types of episodes concerning for focal seizures, all of which were refractory to medications. One event consisted of 30 s of right hand "tingling" accompanied by staring and altered sensorium, without full loss of consciousness. A second event consisted of isolated posturing of the right hand. Several years later, he also developed 1-min episodes of forced rightward gaze and head deviation occurring several times per week. Carbamazepine, lacosamide, topiramate, and levetiracetam were each ineffective.
A surgical work-up was initiated at 16 years of age. Video EEG revealed frequent bursts of bifrontal sharp waves and sharply contoured, high amplitude theta waves (Fig. 1a) . Minute-long episodes of dystonic right hand posturing, with hyperextension of the thumb and distal flexion of the remaining fingers, were without EEG correlate. Episodes of rightward gaze and head deviation were seizures that originated from the left occipital region (Fig. 1b) , lasted 1-2 min, and rarely generalized. Magnetoencephalograhy (MEG) showed rare interictal frontal spikes localized over the bilateral middle and inferior frontal gyri, but no seizures were captured. Repeat MRI demonstrated prominent calcium depositions in the bilateral globus palladi with speckling in the frontal white matter (Fig. 2a-c) . Laboratory work up for endocrinopathy or mitochondrial disease were negative. Whole exome sequencing revealed a paternally derived pathogenic heterozygous mutation in the SLC20A2 gene (c.971C > A, p.S324X) and a heterozygous SCN2A gene variant (c.2063A > G, p.Y688C) of unclear significance, also of paternal origin. The SCN2A mutation affects a highly conserved Contents lists available at ScienceDirect Seizure j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y s e i z cytoplasmic loop of the protein but in silico analysis was inconclusive as to the impact of the mutation on channel function. The patient's father had calcifications on brain MRI, but he remains asymptomatic. In light of the patient's refractory epilepsy, neuroimaging, and multifocal EEG abnormalities, a VNS device was placed with modest improvement in seizure frequency.
The patient's birth and past medical history were otherwise unremarkable. He met early developmental milestones, but did struggle academically. Standardized testing found a full-scale IQ of 83, low-average attention, and academic skills in the low-average range.
Discussion
PFBC is a rare disease, and thus major cohort studies are lacking, but the largest case series to date found that 5-10% of patients have seizures [2] . Reports of patients with PFBC and epilepsy are needed to define this phenotype and provide insight into pathogenic mechanisms. We have described a paediatric patient with PFBC and refractory epilepsy with generalized interictal discharges and focal seizures. The patient had a pathogenic SLC20A2 mutation and an SCN2A variant of unknown significance. Taken in the context of the existing literature, this case illustrates two important points about epilepsy in PFBC: 1) ictal EEG is crucial for evaluation of spells concerning for seizure; and 2) epilepsy may be a polygenic disorder.
As PFBC causes multifocal calcifications, one might expect that seizures and interictal abnormalities would be focal or multifocal in onset. Surprisingly, our patient's initial seizure semiology and interictal EEG suggested a generalized epilepsy, while ictal EEG showed a clear focal onset to seizures. Fjaer et al. [3] described two siblings with PFBC who also had generalized interictal discharges, but ictal EEG findings were not reported. In our patient, EEG was also useful for determining that episodes of hand posturing were not focal seizures and were more likely dystonic events, which occur in a quarter of patients with PFBC [2] . Our case highlights the importance of ictal EEG for the assessment and management of stereotyped events in patients with PFBC.
Fjaer et al. [3] also raised an important possibility that epilepsy in PFBC may be inherited in a digenic or oligogenic manner. The siblings inherited a SLC20A2 mutation from their father and a CHRNB2 mutation (associated with autosomal dominant nocturnal frontal lobe epilepsy with incomplete penetrance) from their mother; neither parent was affected by seizures or clinically evident PFBC, though the father had calcifications on neuroimaging. The authors suggested that the combination of SLC20A2 and CHRNB2 may have been necessary for seizures to manifest. Similarly, our patient has a pathogenic SLC20A2 mutation and a paternally derived heterozygous SCN2A variant of unknown significance. SCN2A encodes the major alpha subunit of the voltage gated sodium channel Nav1.2. With variable penetrance, pathogenic mutations cause diverse epilepsy syndromes including benign familial infantile seizures, GEFS+, Dravet syndrome and infantile epileptic encephalopathy [4] . The patient's father, who harbors identical mutations in both SCN2A and SLC20A2, does not have seizures. Given the incomplete penetrance of SCN2A mutations, the contribution of the SCN2A variant to our patient's epilepsy phenotype is not clear. The rate of epilepsy reported in Fahr's disease (5-10%), is higher than the rate in the general population (0.5-1%), suggesting that the disease itself is a risk factor for epilepsy [2] . Yet the fact that more patients with Fahr's disease do not have epilepsy, together with the possible contribution of additional genetic risk factors in our patient and the siblings reported previously [3] suggest that a "second hit" may be required. Indeed, in some cases, SCN2A mutations are thought to serve as "risk modifiers" in polygenic epilepsy rather than independently pathogenic mutations [4] . Further investigation will be necessary to determine whether epilepsy in PFBC is a polygenic disorder.
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